PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.

COVID-19 COVID-19 Vaccines Humans Reinfection SARS-CoV-2 Seroepidemiologic Studies
COVID-19 SARS-CoV-2 antibodies cohort study reinfection

Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
29 06 2022
Historique:
pubmed: 20 5 2022
medline: 2 7 2022
entrez: 19 5 2022
Statut: ppublish

Résumé

To understand reinfection rates and correlates of protection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we established eight different longitudinal cohorts in 2020 under the umbrella of the PARIS (Protection Associated with Rapid Immunity to SARS-CoV-2)/SPARTA (SARS SeroPrevalence And Respiratory Tract Assessment) studies. Here, we describe the PARIS/SPARTA cohorts, the harmonized assays and analysis that are performed across the cohorts, as well as case definitions for SARS-CoV-2 infection and reinfection that have been established by the team of PARIS/SPARTA investigators.

Identifiants

DOI: 10.1128/msphere.00179-22 PMID: 35586986 PMC: PMC9241545
pubmed: 35586986
doi: 10.1128/msphere.00179-22
pmc: PMC9241545
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0017922

Subventions

Organisme : NIAID NIH HHS
ID : 75N93019C00051
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00052
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet Microbe. 2021 Jul;2(7):e283-e284
pubmed: 33846703
PLoS Pathog. 2021 Apr 8;17(4):e1009453
pubmed: 33831132
Curr Protoc Microbiol. 2020 Jun;57(1):e100
pubmed: 32302069
J Mol Diagn. 2021 Jul;23(7):788-795
pubmed: 33957320
Nature. 2021 Feb;590(7847):630-634
pubmed: 33276369
Lancet Respir Med. 2021 Jul;9(7):712-720
pubmed: 33865504
Microbiol Spectr. 2021 Oct 31;9(2):e0105921
pubmed: 34704832
Open Forum Infect Dis. 2021 Aug 10;8(9):ofab420
pubmed: 34557558
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34369565
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Lancet Infect Dis. 2021 Jan;21(1):52-58
pubmed: 33058797
EBioMedicine. 2021 Dec;74:103748
pubmed: 34902788
Science. 2020 Aug 14;369(6505):818-823
pubmed: 32616673
Clin Infect Dis. 2022 Aug 24;75(1):e705-e714
pubmed: 34891165
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Cell Rep. 2022 Feb 15;38(7):110394
pubmed: 35139368
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
J Immunol. 2021 Sep 1;207(5):1229-1238
pubmed: 34348975
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Ann Intern Med. 2021 Nov;174(11):1572-1585
pubmed: 34461029
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Acad Pathol. 2021 Jun 29;8:23742895211023948
pubmed: 34263025
Nature. 2022 Feb;602(7898):682-688
pubmed: 35016197
Cell Host Microbe. 2022 Jan 12;30(1):83-96.e4
pubmed: 34965382
Vaccines (Basel). 2022 Apr 29;10(5):
pubmed: 35632452
Front Immunol. 2021 Sep 27;12:728021
pubmed: 34646267
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
Eur J Clin Invest. 2021 Apr;51(4):e13520
pubmed: 33583018
Nature. 2021 Aug;596(7870):109-113
pubmed: 34182569
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Nat Commun. 2022 Sep 1;13(1):5135
pubmed: 36050304
EBioMedicine. 2021 Jun;68:103401
pubmed: 34051441
Vaccines (Basel). 2021 Aug 08;9(8):
pubmed: 34452004
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Nature. 2022 May;605(7911):640-652
pubmed: 35361968
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Immunity. 2021 Sep 14;54(9):2159-2166.e6
pubmed: 34464596
Diagnostics (Basel). 2021 May 19;11(5):
pubmed: 34069462
J Infect Dis. 2021 Jul 2;224(1):49-59
pubmed: 33755731
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
N Engl J Med. 2021 Apr 8;384(14):1372-1374
pubmed: 33691060
Nature. 2022 Apr;604(7904):141-145
pubmed: 35168246
Lancet. 2021 Mar 27;397(10280):1204-1212
pubmed: 33743221
EBioMedicine. 2021 Nov;73:103626
pubmed: 34688034
Clin Infect Dis. 2021 Nov 16;73(10):1882-1886
pubmed: 33718968
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34140350
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Viruses. 2021 Oct 14;13(10):
pubmed: 34696495
Science. 2020 Jun 5;368(6495):1060-1061
pubmed: 32414781
Cancer Cell. 2021 Aug 9;39(8):1028-1030
pubmed: 34242572
JAMA Intern Med. 2021 May 1;181(5):672-679
pubmed: 33625463
Nature. 2021 Jul;595(7867):421-425
pubmed: 34030176
Cancer Cell. 2021 Nov 8;39(11):1442-1444
pubmed: 34706273

Auteurs

Viviana Simon (V)

Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.

Vamsi Kota (V)

Department of Medicine, Medical College of Georgia, Augusta Universitygrid.410427.4, Augusta, Georgia, USA.

Ryan F Bloomquist (RF)

Department of Restorative Sciences, Dental College of Georgia, Augusta Universitygrid.410427.4, Augusta, Georgia, USA.

Hannah B Hanley (HB)

Center for Vaccine and Immunology, University of Georgiagrid.213876.9, Athens, Georgia, USA.

David Forgacs (D)

Center for Vaccine and Immunology, University of Georgiagrid.213876.9, Athens, Georgia, USA.

Savita Pahwa (S)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Suresh Pallikkuth (S)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Loren G Miller (LG)

Department of Medicine, David Geffen School of Medicine at UCLAgrid.471398.0, Los Angeles, California, USA.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.

Joanna Schaenman (J)

Department of Medicine, David Geffen School of Medicine at UCLAgrid.471398.0, Los Angeles, California, USA.

Michael R Yeaman (MR)

Department of Medicine, David Geffen School of Medicine at UCLAgrid.471398.0, Los Angeles, California, USA.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.

David Manthei (D)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.

Joshua Wolf (J)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID: 0000-0002-9912-3646

Aditya H Gaur (AH)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Jeremie H Estepp (JH)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Komal Srivastava (K)

Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.

Juan Manuel Carreño (JM)

Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.

Frans Cuevas (F)

Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.

Ali H Ellebedy (AH)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA.
Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, Missouri, USA.

Aubree Gordon (A)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.

Riccardo Valdez (R)

Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.

Sarah Cobey (S)

Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA.

Elaine F Reed (EF)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLAgrid.471398.0, Los Angeles, California, USA.

Ravindra Kolhe (R)

Department of Pathology, Medical College of Georgia, Augusta Universitygrid.410427.4, Augusta, Georgia, USA.
Department of Medicine, Medical College of Georgia, Augusta Universitygrid.410427.4, Augusta, Georgia, USA.
Department of Restorative Sciences, Dental College of Georgia, Augusta Universitygrid.410427.4, Augusta, Georgia, USA.

Paul G Thomas (PG)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID: 0000-0002-2021-727X

Ted M Ross (TM)

Center for Vaccine and Immunology, University of Georgiagrid.213876.9, Athens, Georgia, USA.
Department of Infectious Diseases, University of Georgiagrid.213876.9, Athens, Georgia, USA.
ORCID: 0000-0003-1947-7469

Florian Krammer (F)

Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
ORCID: 0000-0003-4121-776X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › PARIS and SPARTA: Finding the Achilles' Heel...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › PARIS and SPARTA: Finding the Achilles' Heel...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › PARIS and SPARTA: Finding the Achilles' Heel...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Récidive › Réinfection › PARIS and SPARTA: Finding the Achilles' Heel...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › PARIS and SPARTA: Finding the Achilles' Heel...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études séroépidémiologiques › PARIS and SPARTA: Finding the Achilles' Heel...